Enhancing the immunogenicity of exosomes for cancer immunotherapy
Exosomes are small membrane-bound vesicles of endosomal origin secreted by many cell types including tumour cells. Their potential use in cancer immunotherapy has been suggested by the discovery that tumour-derived exosomes can be a source of tumour associated antigens (T AA) and protect against tum...
Main Author: | Ilett, Elizabeth Jane |
---|---|
Published: |
University of Leeds
2007
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.578643 |
Similar Items
-
Tumour-mediated immunosuppression of antigen presenting cells: a potential target for cancer immunotherapy
by: El Refaee, Mohamed
Published: (2013) -
Dosing strategy for effective peptide immunotherapy of experimental autoimmune disease
by: Burton, Bronwen R.
Published: (2011) -
Conjugated linoleic acid : effects on immune functions (ex vivo) and cancer cell signal mechanisms (in vitro)
by: Song, Hyun-Ju
Published: (2004) -
Production of novel monoclonal antibodies to blood group antigens by peptide immunisation
by: Colligan, David Allan
Published: (2007) -
Expression of ADAM8 on cells of the immune system and potential modulation by the mite allergen Der p 1
by: Richens, Joanna
Published: (2007)